From the publishers of JADPRO

Graft-vs.-Host Disease Resource Center

Advertisement

Prospective external validation of biomarkers to predict acute graft-versus host disease severity

Last Updated: Thursday, July 7, 2022

A prospective noninterventional study found that utilizing biomarker panels at the onset of GvHD was associated with survival and non-relapse mortality.

Blood Advances
Advertisement
News & Literature Highlights
Advertisement
Advertisement